Mark Lowenberg

Mark Lowenberg

Amsterdam, NH 1081HZ, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 153 publications

Towards tailored surveillance strategies in inflammatory bowel disease: still a long way to go.

Towards tailored surveillance strategies in inflammatory bowel disease: still a long way to go.

Journal: Journal of Crohn's & colitis

Published: December 29, 2025

Kinetics of intestinal ultrasound and shear-wave elastography to assess early response in ulcerative colitis patients treated with filgotinib.

Kinetics of intestinal ultrasound and shear-wave elastography to assess early response in ulcerative colitis patients treated with filgotinib.

Journal: Journal of Crohn's & colitis

Published: October 28, 2025

Prospective real-world experience with risankizumab in difficult-to-treat Crohn's disease: results from the Dutch Initiative on Crohn and Colitis Registry.

Prospective real-world experience with risankizumab in difficult-to-treat Crohn's disease: results from the Dutch Initiative on Crohn and Colitis Registry.

Journal: Inflammatory bowel diseases

Published: October 03, 2025

Drug repurposing approach for the discovery of therapeutic agents for Crohn's disease-associated intestinal fibrosis.

Drug repurposing approach for the discovery of therapeutic agents for Crohn's disease-associated intestinal fibrosis.

Journal: Journal of Crohn's & colitis

Published: September 30, 2025

Filgotinib Is an Effective and Safe Treatment Option for Difficult-To-Treat Ulcerative Colitis: Real-World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry.

Filgotinib Is an Effective and Safe Treatment Option for Difficult-To-Treat Ulcerative Colitis: Real-World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry.

Journal: United European gastroenterology journal

Published: July 24, 2025

Measuring Fatigue and Heart Rate Variability Using A Wearable Patch in Ulcerative Colitis Patients: A Cross-Sectional Pilot Study.

Measuring Fatigue and Heart Rate Variability Using A Wearable Patch in Ulcerative Colitis Patients: A Cross-Sectional Pilot Study.

Journal: Journal of clinical gastroenterology

Published: July 11, 2025

Letter: Efficacy Versus Effectiveness-An Important Nuance Among Real-World Studies.

Letter: Efficacy Versus Effectiveness-An Important Nuance Among Real-World Studies.

Journal: Alimentary pharmacology & therapeutics

Published: July 09, 2025

Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's Disease.

Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's Disease.

Journal: Inflammatory bowel diseases

Published: June 04, 2025

Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease.

Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease.

Journal: Journal of Crohn's & colitis

Published: May 24, 2025

Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study.

Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study.

Journal: The lancet. Gastroenterology & hepatology

Published: May 15, 2025

TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination.

TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination.

Journal: RMD open

Published: March 25, 2025

Immune-Mediated Thrombocytopenia in an Ulcerative Colitis Patient After Initiating Filgotinib Treatment: A Case Report.

Immune-Mediated Thrombocytopenia in an Ulcerative Colitis Patient After Initiating Filgotinib Treatment: A Case Report.

Journal: Clinical case reports

Published: March 03, 2025

Showing 1-12 of 153

Last Updated: 09/26/2026